What is a renal replacement therapy membrane?
A renal replacement therapy (RRT) membrane is a semi-permeable filter with pores of
approximately 35,000 Da. A logarithmic linear relationship exists between molecular
weight (MW) cut-off and membrane pore size. A 1 kDa MW cut-off corresponds to about
1.3 nm in membrane pore size, whereas a 10 kDa membrane has a pore size of about 2.9
nm. Along this membrane, the diffusion and convection processes can take place. Diffusion
follows a concentration gradient [as in intermittent hemodialysis (IHD)] and is the
ideal method to remove small (< 500 Da) molecules such as creatinine. Convection follows
a hydrostatic pressure gradient [as in continuous veno-venous hemofiltration (CVVH)]
and is the best method to remove middle-large (between 500 Da and 60 kDa, such as
the 13,750 Da beta-2 microglobulin) and large molecules (between 60 to 100kDa, such
as the 70 kDa albumin). The theoretical cut-off is 35 kDa (so only low-middle molecules
will pass the membrane when using convection). When diffusion and convection are used
simultaneously in continuous mode, this is called continuous veno-venous hemodiafiltration
(CVVHDF).[1]
What is a biocompatible membrane?
Biocompatibility refers to any harmful effect induced by the contact of blood with
the dialysis membrane. The formerly used cuprophane membranes caused major blood interface
interactions inducing unwarranted side-effects. Today, biocompatible polysulphone,
polyethersulphone or polyacrylonitrile (PAN) (e.g., Acrylonitrile (AN) 69) membranes
are used.[2]
Which membrane should i choose for the average intensive care unit patient?
A simple polysulphone hemofilter is suitable in a vast majority of patients. This
membrane is robust, cheap, and resistant to contamination (less hydraulic membrane
permeability loss). In contrast with the high-adsorbent PAN membranes, polysulphone
membranes also do not adsorb antibiotics, which facilitates antibiotic adaptation
during continuous RRT (CRRT).[3]
What is the normal porosity of a membrane?
A classic membrane has a cut-off of 30–35 kDa. Membranes used for convection (CVVH)
have similar porosity whereas the cut-off value is lower (approximately 5 kDa) in
diffusion mode (IHD).[9]
In clinical practice, high (60 kDa) or median (50 kDa) cut-off membranes are almost
never used. Higher cut-off membranes may increase the risk of albumin loss.[4]
What membrane surface should be used?
When using unfractionated heparin (UFH) and higher blood flows, surfaces of 1.5 to
2 m2 are needed. Membrane surface can be decreased when regional citrate anticoagulation
(RCA) is used. A 1 m2 surface is ideal, reducing blood-membrane interactions and shear
stress.[5]
Should i pre-coat or soak the membrane before use?
Filter life of most membranes (even under RCA) is improved after soaking them with
5,000 IU/L UFH. Contra-indications for UFH use should always be considered.[6]
How frequently should i change the membrane?
In the UFH era, it was recommended to change the membrane every 24 to 48 h guided
by filter pressure drop and transmembrane pressure (TMP) increase. RCA, however, enables
to maintain filter porosity up to 72 or 96 h.[7]
What is meant by membrane clotting?
Membrane clotting means that thrombosis occurs at the intra-arterial side of the membrane.
This occurs relatively early during continuous RRT.
For example: Access pressure -70 mmHg (-50 to -150 mmHg); Return pressure 90 mmHg
(50 to 150 mmHg); Filter pressure 350 mmHg (100 to 250 mmHg) = indicative of filter
clotting.
This can be monitored over time by assessing the pressure drop (P-Drop), which is
the pressure reduction that occurs as blood flow passes the filter (P-Drop = Filter
pressure – Return pressure).
For example: Baseline Filter pressure is 100 mm Hg and Return pressure 90 mm Hg. Thus,
P-Drop is 10 mm Hg and low. After 24 h, Filter pressure has increased to 200 mm Hg
and Return pressure is 110 mm Hg. Now, P-Drop is 90 mmHg which suggests membrane clotting.[8]
How can i detect and prevent membrane clotting?
Membrane clotting is detected by closely monitoring P-Drop and Filter pressure. When
early (< 6 h) filter clotting occurs, the venous access must be checked and eventually
flushed with normal saline. In case of UFH use, clotting can be prevented by increasing
the filtration fraction (increasing blood flow without increasing ultrafiltration
[UF] rate or vice versa).[8]
What is meant by membrane clogging?
Membrane clogging occurs later than clotting and is characterized by the formation
of a protein “cake”. Protein progressively obturates the membrane pores from the blood
side. Accordingly, the TMP needed to suck out water and molecules will increase to
a point that the membrane function becomes ineffective. A persistent and gradual rise
in TMP usually indicates filter clogging. This is usually accompanied by a gradual
filter pressure rise and effluent pressure drop. Observing this trend together with
a TMP exceeding +300 mmHg, requires filter replacement. TMP represents the pressure
exerted on the filter membrane during operation (TMP = Filter pressure + Return pressure
/2 – Effluent pressure) and is recorded automatically.[9]
How can i detect and prevent membrane clogging?
Membrane clogging is detected by the close monitoring of TMP and UF pressure. It can
be avoided by decreasing the UF rate and thus TMP or by using RCA instead of UFH for
anticoagulation.[9]
What is meant by filtration fraction?
The filtration fraction (FF) represents the percentage of plasma that is removed as
UF and then replaced by substitution fluid. Under UFH anticoagulation, filtration
fraction (FF) should remain between 16 and 20% to avoid filter clotting. RCA allows
FF levels up to 30–33%. As such, blood flow needed to obtain adequate UF can be reduced
and a vascular access allowing 150 mL/min will be sufficient. UFH anticoagulation,
depending on the patient’s body weight, requires 250 to 350 mL/min to keep the FF
below 20%. In other words, the FF is the fraction of plasma water removed from the
blood during UF. It should be kept in the range of 16–20% to avoid equalization of
oncotic pressure to TMP and filtration/pressure equilibrium. This can be expressed
as: (Post -Dilution + Pre-Dilution + Filter Loss) / (Blood Flow + Pre-Dilution). Ideally,
the formula should also include the hematocrit in the Hemofilter but the latter is
not regularly controlled.[10]
What FF is preferred when using unfractionated heparin?
FF should be kept between 16 and 20%.Variations of FF will depend on the ratio between
blood flow and UF rate. To keep FF low, a blood flow up to 350–400 mL/min might be
needed in obese patients.[10]
What FF is preferred when using regional citrate anticoagulation?
RCA allows an FF up to 30–33%. Therefore, the same UF rate is obtained at lower blood
flow.[11]
What is the sieving coefficient?
The Sieving Coefficient (SC) is the ratio of UF to plasma solute concentration.
SC = 1 reflects complete permeability (for urea and creatinine);
SC = 0 reflects complete impermeability;
SC > 1 requires an external energy source.
During UF, the driving pressure forces solutes (such as urea and creatinine) against
the membrane. The extent of solute penetration through the pores of the membrane is
determined by the membrane SC for that molecule.
Major factors determining the SC are solute molecular size, protein binding, volume
of distribution and filter porosity.[12]
What should be the TMP in adult RRT?
A TMP between 50 and 250 mm Hg is acceptable for adult CRRT. When TMP exceeds 300
mmHg, the membrane must be changed.[13]
What should be the TMP in pediatric or neonatal RRT?
In the pediatric and neonatal setting, a membrane change must be performed when TMP
exceeds 450 mmHg. This is due to the fact that the membrane has a much smaller surface
and thus needs and tolerates a higher TMP.[13]
What is meant by the Haemopermeability index?
The Hemopermeability Index (HPI) is the spontaneous UF rate divided by the TMP and
reflects the functional capacity of the membrane. A decrease of spontaneous UF rate
for the same TMP suggests membrane clogging. HPI is mostly used during spontaneous
UF during cardiac surgery.[14]
How must the new adsorptive membranes be judged?
The clinical superiority of the novel adsorptive AN-69 oXiris, AN-69-surface treated
(ST) or Poly(methyl methacrylate) (PMMA) membrane has not been established. Of note
is that hydrophilic antibiotics are largely adsorbed by these membranes, necessitating
significant dose adjustments.[15]
Which drugs are removed by CRRT?
Un(protein)bound and low (< 500Da) MW drugs are removed (e.g., salicylates, methanol,
ethylene glycol, barbiturates, lithium, penicillin, carbapenems, aminoglycosides,
cephalosporins, vancomycin, metformin, etc.).[16]
Which drugs are not removed by CRRT?
Protein-bound agents, high MW drugs, and drugs with a high volume of distribution
are not removed (e.g., digoxin, tricyclic antidepressants, phenytoin, benzodiazepines,
betablockers (except atenolol), etc.).[16]
What are high-flux membranes?
High-flux membranes have a larger pore size and thus increase the clearance by allowing
larger molecules to pass through the membrane (at least in theory) as well as more
UF flow for the same TMP. Almost all novel biocompatible CRRT membranes are of high-flux
type.[17]